Dr. Jacqueline A. Mullvain, MD

Dr. Mullvain practices at SSM Health St. Mary's Hospital - Madison in Madison, Wisconsin, part of SSM Health Care.

Dr. Mullvain's NPI, 1528387131, was assigned on May 21, 2010. Dr. Mullvain holds Wisconsin license 60345-20.

Dr. Mullvain's primary practice is SSM Health St. Mary's Hospital - Madison, at 700 South Park St, Madison, WI 53715 in Dane County. The practice phone is (608) 251-6100.

Dr. Mullvain's primary practice is SSM Health St. Mary's Hospital - Madison in Madison, Wisconsin, part of SSM Health Care. Dr. Mullvain is also affiliated with SSM Health St. Clare Hospital - Baraboo. The medical group on file is SSM Health Dean Medical Group. Dmand AI also links Dr. Mullvain to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mullvain practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mullvain's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mullvain is licensed in Wisconsin.

CMS data shows 14,239 Medicare services from Dr. Mullvain across 22 procedure codes in 2024, for 228 Medicare patients. Medicare paid $443,054 for them.

CMS counts 228 Medicare patients who saw Dr. Mullvain in 2024. The largest group is 65 to 74, with 109 patients. 67% of them have cancer, and 67% have high blood pressure. 9% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mullvain's median patient age at 70, with 60% women.

In 2024, Dr. Mullvain wrote 723 Medicare Part D claims for 140 patients. 82% of them were for generic drugs. CMS names the drug for 438 of them, across 19 drugs with 11 or more claims each, at $703,949 in total drug cost. In 2023, CMS named 557 claims across 24 drugs.

Dr. Mullvain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mullvain as offering telehealth.

Dmand AI links 3 papers to Dr. Mullvain in 2015. 2015 was the busiest year, with 3. Dr. Mullvain's most frequent co-authors are Toby Christopher Campbell, MD, Lance T. Hall, MD and Kevin R. Kozak, MD, PhD.

CMS Open Payments shows 2 general payments to Dr. Mullvain from 2 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 85% of the total. AstraZeneca Pharmaceuticals LP paid the most, $122.